ALS

Amyotrophic lateral sclerosis (also called motor neuron disease or Lou Gehrig’s disease) is a devastating neurodegenerative disease affecting motor neurons in the brain and spinal cord. It’s also associated with the production of inflammatory mediators by the microglia cells.

Approximately 20,000 Americans live with ALS, and an estimated 5,000 people are diagnosed with the disease each year. The progressive destruction of motor neurons leads to malfunction of neuromuscular connections and to muscle paralysis.

Since there is currently no long-term effective treatment for this condition, any improvement in delaying further degeneration or restoring neurological function would be a major step forward. This makes it a good target for stem cell therapy.

Research studies include stimulating endogenous neural stem cells located in small numbers in “niches” and reservoirs in the nervous system, which results in decreasing the microglia inflammatory process with compounds that have neuroprotective properties.

The use of stem cells derived from the umbilical cord blood is a new development. Researchers are now able to expand the number of umbilical cord blood stem cells and grow them in a culture with specific growth factors. As a result,  cells differentiate into specific cell lines including precursors of selective neural cells populations.

Despite the early stage of stem cell research for ALS, studies performed in animal models suggest that if “healthy stem cells could get to the spinal cord of ALS patients their survival might be extended”. Recent trials have shown promising results when stem cells are implanted into the spinal canal.

Cellulogix now offers cell therapies for ALS patients that include both umbilical cord blood stem cell treatment and/ or stem cell aphaeresis with the use of stem cells collected from the patient’s peripheral blood.

Cell therapy is combined with a comprehensive holistic approach. The entire treatment takes five days to complete and includes lifestyle and diet recommendations, personalized natural supplements, a prescription for neuron support, and light physical therapy.

Post-treatment, patients are asked to submit regular neurological examinations; MRI, PET scan of the brain, and other laboratory tests, in order to monitor their progress.

Industry News

Stanford University Awarded over $5M for Research

Stanford University Medical Center. Four researchers at the Stanford University School of Medicine have been awarded just over $5.5 million for their stem cell research projects.
The California Institute for Regenerative Medicine is now funding projects that are attempting to find ways to overcome immune system rejection of transplanted stem cells. The institute is the state [...]

Read More

Patient Shares Comments Re: His Progress Since Treatment for Ataxia

Dear Cellulogix:   I’m Phil D. and I had my transplant the week of May 5th 2009.  We have communicated several times in the past but not lately. I had my 13th month post transplant exam with my Neurologist yesterday June 18th and thought Dr.Nabavi and you would be interested in an update on my condition. [...]

Read More

New Stem Cell Center At UC Irvine

Hub of hope and healing
Dedication of UCI’s Gross Hall is milestone in effort to unlock stem cells’ potential
 Daniel A. Anderson / University Communications
The May 14 dedication of UCI’s Sue & Bill Gross Hall: A CIRM Institute was a milestone in the effort to unlock stem cells’ potential. Here, CIRM fellows are briefed before leading guest [...]

Read More

Need to Send Medical Records?

Cellulogix recently added the Doc’s@cellulogix email address for our patients to send in their medical reports and all other pertinent information that may be requested. This is helpful if you want our team of specialists to have your medical information prior to your initial consultation as well as follow up reports that are requested.

Read More